Advanced Accelerator Applications Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
1,023
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$224M
- Investors
-
1
Advanced Accelerator Applications General Information
Description
Developer of nuclear medicine intended to deliver targeted radioligand therapies and precision imaging radioligands for oncology. The company's medicine focuses on neuroendocrine and prostate cancer and is engaged in developing and delivering medicines and therapies used in clinical oncology, cardiology, neurology, and infectious or inflammatory diseases, enabling clients to aim at improving patients quality of life
Contact Information
Website
www.adacap.com(Operating Subsidiary)
Corporate Office
- 8 rue Henri Sainte-Claire Deville
- CS 10150, Cedex
- Rueil-Malmaison
- France
Corporate Office
- 8 rue Henri Sainte-Claire Deville
- CS 10150, Cedex
- Rueil-Malmaison
- France
Advanced Accelerator Applications Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 10-Dec-2024 | $224M | Completed | Generating Revenue | ||
| 8. Merger/Acquisition | 22-Jan-2018 | Completed | Generating Revenue | |||
| 7. IPO | 16-Nov-2015 | Completed | Clinical Trials - Phase 3 | |||
| 6. Later Stage VC | 23-Jun-2015 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC | 17-Feb-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 25-Jul-2011 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 30-Apr-2009 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 10-Nov-2006 | $8.25M | $8.25M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Advanced Accelerator Applications Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 3,500,000 | $0.111756 | $1.12 | $1.12 | 1x | $1.12 | 5.22% | |
| Ordinary Shares | 5,680,000 | $0.111756 | $0.59 | $0.59 | 1x | $0.59 | 8.48% |
Advanced Accelerator Applications Comparisons
Industry
Financing
Details
Advanced Accelerator Applications Competitors (35)
One of Advanced Accelerator Applications’s 35 competitors is Alliance Medical, a Private Equity-Backed company based in Warwick, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alliance Medical | Private Equity-Backed | Warwick, United Kingdom | ||||
| Bluebird Bio | Formerly VC-backed | Somerville, MA | ||||
| Navidea Biopharmaceuticals | Corporation | Dublin, OH | ||||
| Athos Therapeutics | Venture Capital-Backed | Los Angeles, CA | ||||
| Jubilant Therapeutics | Corporation | Allentown, PA |
Advanced Accelerator Applications Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Advanced Accelerator Applications Patents
Advanced Accelerator Applications Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3235923-A1 | Methods for large scale synthesis of radionuclide complexes | Pending | 04-Feb-2022 | ||
| EP-4472678-A1 | Methods for large scale synthesis of radionuclide complexes | Pending | 04-Feb-2022 | ||
| AU-2022384793-A1 | Combination therapy for treating lung cancer | Pending | 12-Nov-2021 | ||
| EP-4429717-A1 | Combination therapy for treating lung cancer | Pending | 12-Nov-2021 | ||
| CA-3240096-A1 | Combination therapy for treating lung cancer | Pending | 12-Nov-2021 | A61K51/088 |
Advanced Accelerator Applications Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Advanced Accelerator Applications Former Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adage Capital Management | Hedge Fund | Minority | ||
| Boesen B.V. | Venture Capital | Minority | ||
| Carpefin | Corporation | Minority | ||
| Catalyst Energy Technologies | Venture Capital | Minority | ||
| Cibra Ltd | Venture Capital | Minority |
Advanced Accelerator Applications Investments & Acquisitions (15)
Advanced Accelerator Applications’s most recent deal was a Early Stage VC with Altheia Science for . The deal was made on 19-Dec-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Altheia Science | 19-Dec-2018 | Early Stage VC | Biotechnology | ||
| F-18 radiopharmaceutical Production Sites | 26-May-2016 | Corporate Asset Purchase | Buildings and Property | ||
| IDB Holland | 07-Jan-2016 | Merger/Acquisition | Biotechnology | ||
| Atreus Pharmaceuticals | 05-Jan-2015 | Corporate | Biotechnology | ||
| Umbra Medical | 01-Dec-2014 | Corporate | Biotechnology |
Advanced Accelerator Applications Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Umbra Medical | Cologne, Germany | 2008 | |
| Imaging Equipment | Chilcompton, United Kingdom | 2001 | |
| Biosynthema | Saint Louis, MO | 2001 | |
| IDB Holland | Baarle-Nassau, Netherlands | 1982 |
Advanced Accelerator Applications FAQs
-
When was Advanced Accelerator Applications founded?
Advanced Accelerator Applications was founded in 2002.
-
Where is Advanced Accelerator Applications headquartered?
Advanced Accelerator Applications is headquartered in Rueil-Malmaison, France.
-
What is the size of Advanced Accelerator Applications?
Advanced Accelerator Applications has 1,023 total employees.
-
What industry is Advanced Accelerator Applications in?
Advanced Accelerator Applications’s primary industry is Other Healthcare Services.
-
Is Advanced Accelerator Applications a private or public company?
Advanced Accelerator Applications is a Private company.
-
What is the current valuation of Advanced Accelerator Applications?
The current valuation of Advanced Accelerator Applications is .
-
What is Advanced Accelerator Applications’s current revenue?
The current revenue for Advanced Accelerator Applications is .
-
How much funding has Advanced Accelerator Applications raised over time?
Advanced Accelerator Applications has raised $239M.
-
Who are Advanced Accelerator Applications’s investors?
Adage Capital Management, Boesen B.V., Carpefin, Catalyst Energy Technologies, and Cibra Ltd are 5 of 25 investors who have invested in Advanced Accelerator Applications.
-
Who are Advanced Accelerator Applications’s competitors?
Alliance Medical, Bluebird Bio, Navidea Biopharmaceuticals, Athos Therapeutics, and Jubilant Therapeutics are some of the 35 competitors of Advanced Accelerator Applications.
-
When was Advanced Accelerator Applications acquired?
Advanced Accelerator Applications was acquired on 10-Dec-2024.
-
Who acquired Advanced Accelerator Applications?
Advanced Accelerator Applications was acquired by Siemens Healthineers.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
